Correction of Kakao Healthcare External Investment and Equity Structure Change

Correction: Details of 2nd capital increase for Kakao Healthcare (amounts, dates) finalized; total investment remains 100 billion KRW
2nd capital increase (Kakao): 40 billion KRW (8,487,163 common shares), payment date 2026-04-30, 34 billion KRW cash + 6 billion KRW debt offset
2nd capital increase (other investors): Total 50.2 billion KRW (10,634,770 preferred shares) confirmed; IMM Growth Venture Fund 2nd: 20 billion KRW (paid 2026-03-20), 2nd-2: 27 billion KRW (scheduled 2026-04-30), GS Assembly: 3 billion KRW (paid 2026-03-20)
Post-2nd transaction shareholding: Cha Bio Group 43.06%, Kakao 29.97%, other investors 26.97%
Acquirer role transferred from IMM Investment to IMM Growth Venture Fund 2nd-2
2nd capital increase is conditional (proceeds only if full 90 billion KRW raised); may be cancelled if insufficient

Filing: [Correction of Description] Other Management Matters (Voluntary Disclosure)
Company: Kakao (035720)
Submission: Kakao Corp.
Receipt: 04-30-2026
Under KRX KOSPI Market Division, Amended (Refer to related filing)